Market Overview
The global Dysmenorrhea
Treatment Market Size is expected to cross USD 7.69 billion
by 2032 at a CAGR of 8.20% during the forecast period 2023-2032.
Recently the outbreak of the Covid-19 pandemic
has globally vastly impacted women's health. The pandemic affected the female
population and made them face an extended period of illness that also inclined
towards the increasing duration of the menstrual cycle, which severely affected
the women and led to several health issues.
Dysmenorrhea is generally classified as
menstrual cramps, which harshly affects women's health. The major factors
attributed to channelizing the Dysmenorrhea Treatment Market. growth are the rapidly increasing rate of
Dysmenorrhea among teenage girls. Due to genetic disorders, menstrual cramps
are also gripping rapid effects among women. Concerns beholding to the harsh
effects and increasing availability of various products are implied to curb the
market's growth. The increasing population of females and rapidly growing
menstrual health issues is developing openings for Dysmenorrhea
Treatment Market.
Key Players:
Global dysmenorrhea treatment market Players are including.
Johnson & Johnson (US),
GlaxoSmithKline PLC (UK),
F. Hoffmann-La Roche Ltd (Switzerland),
Bayer AG (Germany),
Focus Consumer Healthcare, LLC (US),
Novartis AG (Switzerland),
Pfizer, Inc. (US),
Reckitt Benckiser Group plc. (UK),
Sanofi S.A. (France) and
Viatris Inc. (US) among others.
Market Segmentation:
The Dysmenorrhea
Treatment Market has
been segmented based on type, type of treatment, and end-user.
By type includes primary Dysmenorrhea, which
happens before menstrual bleeding women will face recurring and very painful menstrual
cramps. The pain is likely to be high in the back, lower abdomen, or thigh and
mild to severe. It lasts up to 12 to 72 hours. Nauseous, fatigue,
diarrhea, and vomiting are some of the symptoms of primary Dysmenorrhea. Then
comes the secondary Dysmenorrhea, and It is studied that endometriosis is the
leading cause of secondary Dysmenorrhea among adolescent women.
On the factors of treatment Dysmenorrhea
Treatment Market has been segmented into pain relievers,
hormonal therapy, surgery, and others. The market is dealing well with the
medication procedure as the growth of menstrual problems is a rising rapidly
day by day. The Dysmenorrhea Treatment Market is
divided into parts based on end-users, such as hospitals, clinics, research
centers, and others.
Other end-users, such as ambulatory surgical
centers and specialty centers, are also other end-users. In ambulatory surgical
centers, methods can be performed on the same day.
Regional Analysis:
Based on the region, the global Dysmenorrhea
Treatment Market has been fractionated into the Americas,
Europe, Asia-Pacific, and the the Middle East and Africa.
It is subjected that Americas accounted for
the biggest share in the field of Dysmenorrhea Treatment Market. Due
to the increasing number of women suffering from Dysmenorrhea, the treatment
market is strongly holding its pace rapidly. Along with this, other regions are
also developing their need for Dysmenorrhea Treatment Market.
Industry News:
Recently, a company known as
GlaxoSmithKlinePlC, based in the UK, has involved itself with Dysmenorrhea
Treatment Market and planning to introduce new medications
and developmental aspects for this serious menstrual issue.
Related
Reports-
Hemiplegic Migraine Market Research
Report - Forecast till 2023
Medical Bionic Implant/Artificial
Organs Market Research Report รข€“ Forecast to 2030
Digital 3D Printing Market Research Report - Global Forecast till
2030
About
US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
